{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:46:56Z","timestamp":1791704816170,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["SJCX24_0759"],"award-info":[{"award-number":["SJCX24_0759"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872126"],"award-info":[{"award-number":["81872126"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472707"],"award-info":[{"award-number":["82472707"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.tranon.2026.103056","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:49:46Z","timestamp":1790858986000},"page":"103056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A membrane-penetrating modified ascites-derived peptide, TAT-CPAP1, sensitizes TP53 wild-type ovarian cancer cells to platinum-based therapy through targeting the NOLC1-MDM2\/MDM4 axis"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8313-843X","authenticated-orcid":false,"given":"Zhe","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjie","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9323-4425","authenticated-orcid":false,"given":"Xuemei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2026.103056_bib0001","first-page":"10","article-title":"Cancer statistics","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.tranon.2026.103056_bib0002","first-page":"284","article-title":"Ovarian cancer statistics","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.tranon.2026.103056_bib0003","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.tranon.2026.103056_bib0004","doi-asserted-by":"crossref","first-page":"viii13","DOI":"10.1093\/annonc\/mdx446","article-title":"Acquired chemotherapy resistance in ovarian cancer","volume":"28","author":"Christie","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.tranon.2026.103056_bib0005","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","article-title":"Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research","volume":"13","author":"Kipps","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.tranon.2026.103056_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.684505","article-title":"Cancer-Associated Fibroblast-Derived Interleukin-8 Promotes Ovarian Cancer Cell Stemness and Malignancy Through the Notch3-Mediated Signaling","volume":"9","author":"Ji","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.tranon.2026.103056_bib0007","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/s41591-020-0926-0","article-title":"A single-cell landscape of high-grade serous ovarian cancer","volume":"26","author":"Izar","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.tranon.2026.103056_bib0008","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ygyno.2007.10.018","article-title":"Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy","volume":"108","author":"Bamias","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tranon.2026.103056_bib0009","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.4161\/cc.29951","article-title":"The bright side of ascites in ovarian cancer","volume":"13","author":"Cohen","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tranon.2026.103056_bib0010","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1158\/0008-5472.CAN-04-1272","article-title":"Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer","volume":"64","author":"Curiel","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.tranon.2026.103056_bib0011","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1111\/cas.13775","article-title":"Novel therapeutic strategies for advanced ovarian cancer by using induced pluripotent stem cell-derived myelomonocytic cells producing interferon beta","volume":"109","author":"Imamura","year":"2018","journal-title":"Cancer Sci"},{"key":"10.1016\/j.tranon.2026.103056_bib0012","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.psyneuen.2019.04.007","article-title":"Oxytocin in the tumor microenvironment is associated with lower inflammation and longer survival in advanced epithelial ovarian cancer patients","volume":"106","author":"Cuneo","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.tranon.2026.103056_bib0013","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1158\/1535-7163.MCT-21-0848","article-title":"Peptide PDHPS1 Inhibits Ovarian Cancer Growth through Disrupting YAP Signaling","volume":"21","author":"Pan","year":"2022","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.tranon.2026.103056_bib0014","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.dib.2018.12.056","article-title":"Peptidome profiling dataset of ovarian cancer and non-cancer proximal fluids: Ascites and blood sera","volume":"22","author":"Shender","year":"2019","journal-title":"Data Brief"},{"key":"10.1016\/j.tranon.2026.103056_bib0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/IGC.0000000000001166","article-title":"Potential Significance of Peptidome in Human Ovarian Cancer for Patients With Ascites","volume":"28","author":"Huang","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.tranon.2026.103056_bib0016","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.biocel.2018.12.004","article-title":"Mass spectrometry-based peptidome profiling of human serous ovarian cancer tissues","volume":"107","author":"Xu","year":"2019","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.tranon.2026.103056_bib0017","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1021\/nn4057269","article-title":"Cell-penetrating peptides: design, synthesis, and applications","volume":"8","author":"Copolovici","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.tranon.2026.103056_bib0018","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00232-016-9940-z","article-title":"Progress in Research and Application of HIV-1 TAT-Derived Cell-Penetrating Peptide","volume":"250","author":"Zou","year":"2017","journal-title":"J Membr Biol"},{"key":"10.1016\/j.tranon.2026.103056_bib0019","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1038\/onc.2016.12","article-title":"Heterozygous p53(V172F) mutation in cisplatin-resistant human tumor cells promotes MDM4 recruitment and decreases stability and transactivity of p53","volume":"35","author":"Xie","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.tranon.2026.103056_bib0020","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1002\/jcp.26369","article-title":"Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells","volume":"233","author":"Xu","year":"2018","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.tranon.2026.103056_bib0021","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1101\/gad.261867.115","article-title":"A common polymorphism in the 5\u2032 UTR of ERCC5 creates an upstream ORF that confers resistance to platinum-based chemotherapy","volume":"29","author":"Somers","year":"2015","journal-title":"Genes Dev"},{"key":"10.1016\/j.tranon.2026.103056_bib0022","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1038\/s41467-020-17127-2","article-title":"Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models","volume":"11","author":"Kim","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.tranon.2026.103056_bib0023","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.canlet.2016.08.018","article-title":"Proteasome activator subunit 3 promotes pancreatic cancer growth via c-Myc-glycolysis signaling axis","volume":"386","author":"Guo","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1016\/j.tranon.2026.103056_bib0024","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4161\/auto.22399","article-title":"BCL2L11\/BIM: a novel molecular link between autophagy and apoptosis","volume":"9","author":"Luo","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.tranon.2026.103056_bib0025","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/embor.2013.25","article-title":"Another fork in the road\u2013life or death decisions by the tumour suppressor p53","volume":"14","author":"Carvajal","year":"2013","journal-title":"EMBO Rep"},{"key":"10.1016\/j.tranon.2026.103056_bib0026","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrm4007","article-title":"p53 in survival, death and metabolic health: a lifeguard with a licence to kill","volume":"16","author":"Kruiswijk","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.tranon.2026.103056_bib0027","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2353\/ajpath.2009.080931","article-title":"NOLC1, an enhancer of nasopharyngeal carcinoma progression, is essential for TP53 to regulate MDM2 expression","volume":"175","author":"Hwang","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.tranon.2026.103056_bib0028","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.4161\/cc.10.20.17687","article-title":"Ribosome biogenesis and p53: who is regulating whom?","volume":"10","author":"Krastev","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tranon.2026.103056_bib0029","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1124\/mol.119.117564","article-title":"Cisplatin in Combination with MDM2 Inhibition Downregulates Rad51 Recombinase in a Bimodal Manner to Inhibit Homologous Recombination and Augment Tumor Cell Kill","volume":"97","author":"Xie","year":"2020","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.tranon.2026.103056_bib0030","doi-asserted-by":"crossref","first-page":"19251","DOI":"10.1074\/jbc.C200150200","article-title":"Mutual dependence of MDM2 and MDMX in their functional inactivation of p53","volume":"277","author":"Gu","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tranon.2026.103056_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104434","article-title":"Clinical and molecular features of platinum resistance in ovarian cancer","volume":"201","author":"Miras","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.tranon.2026.103056_bib0033","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/ncb2264","article-title":"A systematic RNAi synthetic interaction screen reveals a link between p53 and snoRNP assembly","volume":"13","author":"Krastev","year":"2011","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.tranon.2026.103056_bib0034","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0092-8674(92)90539-O","article-title":"Nopp140 shuttles on tracks between nucleolus and cytoplasm","volume":"70","author":"Meier","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2026.103056_bib0035","doi-asserted-by":"crossref","first-page":"8536","DOI":"10.1128\/MCB.19.12.8536","article-title":"Human Nopp140, which interacts with RNA polymerase I: implications for rRNA gene transcription and nucleolar structural organization","volume":"19","author":"Chen","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.tranon.2026.103056_bib0036","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/acel.12602","article-title":"Enhanced NOLC1 promotes cell senescence and represses hepatocellular carcinoma cell proliferation by disturbing the organization of nucleolus","volume":"16","author":"Yuan","year":"2017","journal-title":"Aging Cell"},{"key":"10.1016\/j.tranon.2026.103056_bib0037","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s11658-018-0119-8","article-title":"Identification and validation of NOLC1 as a potential target for enhancing sensitivity in multidrug resistant non-small cell lung cancer cells","volume":"23","author":"Huang","year":"2018","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.tranon.2026.103056_bib0038","article-title":"Nucleolar and Coiled-Body Phosphoprotein 1 Is Associated With Stemness and Represents a Potential Therapeutic Target in Triple-Negative Breast Cancer","volume":"12","author":"Chen","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.tranon.2026.103056_bib0031","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1038\/emboj.2009.154","article-title":"MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway","volume":"28","author":"Mancini","year":"2009","journal-title":"EMBO J"},{"key":"10.1016\/j.tranon.2026.103056_bib0039","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13058-021-01406-x","article-title":"First in class dual MDM2\/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models","volume":"23","author":"Pairawan","year":"2021","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.tranon.2026.103056_bib0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13045-023-01453-1","article-title":"Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy","volume":"16","author":"Yang","year":"2023","journal-title":"J Hematol Oncol"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193652332600392X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193652332600392X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:29:57Z","timestamp":1791703797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193652332600392X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":40,"alternative-id":["S193652332600392X"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103056","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A membrane-penetrating modified ascites-derived peptide, TAT-CPAP1, sensitizes TP53 wild-type ovarian cancer cells to platinum-based therapy through targeting the NOLC1-MDM2\/MDM4 axis","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103056"}}